Helius Medical Technologies Inc HSDT

Healthcare Medical Devices

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

NDAQ:HSDT - Post by User

Helius Medical Technologies Inc

Bullboard Posts

Comment by prokofievon Mar 06, 2019 4:45pm

167 Views

Post# 29452055

RE:RE:RE:RE:RE:RE:RE:Oppenheimer: Initiating Coverage With Outperform Rating

I would also add that the FDA does not tell anyone when they will get approval... Not even Helius' management team lol... So them not knowing, not sure how they are supposed to let anyone else know.

Prokofiev

Dvorak12 wrote: What do you mean confidential discussions with management??? Management does not disclose non public information to analysts any more that they disclose it to anyone else.

The analyst doesn't have any 'secret' insight that everyone else does not.

miningfundi wrote: Any competent analyst would base his FDA assumption on confidential discussions with management,